WUXIAPPTEC：(Re-publishedfordebtholders'information)InterimReport2020.pdf

1、Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in relian

2、ce upon the whole or any part of the contents of this announcement.WUXI APPTEC CO.,LTD.*(A joint stock company incorporated in the Peoples Republic of China with limited liability)(Stock Code:2359)無錫藥明康德新藥開發股份有限公司INTERIM REPORT 2020The content of this document has been published using the equity sto

3、ck code(Stock Code:2359)on September 14,2020 and is now re-published using the debt stock code(Stock Code:6015)for the debt holders information.By order of the Board WuXi AppTec Co.,Ltd.*Dr.Ge LiChairmanHong Kong,September 16,2020As of the date of this announcement,the Board of the Company comprises

4、 Dr.Ge Li,Mr.Edward Hu,Dr.Steve Qing Yang,Mr.Zhaohui Zhang and Dr.Ning Zhao as executive Directors,Mr.Xiaomeng Tong and Dr.Yibing Wu as non-executive Directors and Dr.Jiangnan Cai,Ms.Yan Liu,Mr.Dai Feng,Dr.Hetong Lou and Mr.Xiaotong Zhang as independent non-executive Directors.*For identification pu

5、rposes only?中 期 報 告無錫藥明康德新藥開發股份有限公司WuXi AppTec Co.,Ltd.*(A joint stock company incorporated in the Peoples Republic of China with limited liability)Stock Code:2359股份代碼：2359（於中華人民共和國註冊成立的股份有限公司）無錫藥明康德新藥開發股份有限公司WuXi AppTec Co.,Ltd.*WuXi AppTec Co.,Ltd.*INTERIM REPORT 2020 中期報告CMYCMMYCYCMYKai1599547296

6、33_wuxi apptec IR2020 Cover 15.1mm output.pdf 1 8/9/2020 下午2:41CONTENTSCorporate Information 2Financial Highlights4Management Discussion and Analysis5Statutory Disclosures40Report on Review of Condensed Consolidated Financial Statements64Condensed Consolidated Statement of Profit or Loss and Other C